Q2 2025 Results Conference Call February 6, 2025 10:30 AM ETCompany ParticipantsKellie Smythe - Senior Director ...
Funded by a one-year, $500,000 grant from the National Institutes of Health (NIH)’s AIM AHEAD program, the researchers are ...
Initiation of Phase 1/2 combination trial with PYX-201, an extracellular ADC targeting Extradomain-B Fibronectin (EDB+FN) and Merck’s KEYTRUDA® ...
California Polytechnic State University and FullStack Modular will develop 4,200 on-campus student housing beds across nine ...
Funded by a one-year, $500,000 grant from the National Institutes of Health (NIH)’s AIM AHEAD program, the researchers are ...
Random Matrix Theory (RMT): A field of mathematics that studies the properties of matrices with random entries, often used to understand complex systems in physics and other disciplines.
I am writing to voice concerns over the findings of the phase 3 trial of the R21/Matrix-M malaria vaccine by Mehreen Datoo and colleagues.1 The study indicates that the vaccine's efficacy appears to ...
Fury Gold Mines Limited (TSX and NYSE American: FURY) (“Fury” or the “Company”) announces that a drill has been mobilized to ...
The private AI cloud deployment is set to transform operational efficiency and drive innovation within e&’s operations in the ...
A joint venture including Gilbane Development Co. closed on the second phase of Barnaby & 7th's redevelopment in Washington, D.C.
Dynavax should take a leaf from its vaccine maker peer, Novavax, and work to monetize its CpG1018 adjuvant. Learn more about ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results